Stock analysts at Citigroup started coverage on shares of Emerson Electric (NYSE:EMR – Get Free Report) in a research note ...

| It built an open-source AI-enabled clinical copilot for clinicians, called Hyperscribe, and developed it with the Canvas software development kit.

Emerson Electric (EMR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

In a report released today, Julian Mitchell from Barclays downgraded Emerson Electric Company (EMR – Research Report) to a Sell, with a price ...

Fintel reports that on March 10, 2025, Barclays downgraded their outlook for Emerson Electric (NYSE:EMR) from Equal-Weight to ...

Emerson Electric (NYSE:EMR) experienced a 4% decline in its share price over the past week, amid its announcement that board member Leticia Gonçalves Lourenco resigned due to changes in her principal ...

UBS Group began coverage on Emerson Electric in a research report on Wednesday, November 13th. They set a “neutral” rating and a $135.00 price objective for the company. BNP Paribas began ...

SAN FRANCISCO, March 18, 2025 /PRNewswire/ -- Canvas Medical, the EMR company accelerating everyday medicine, today announced the launch of Hyperscribe, an open source artificial intelligent (AI ...

A massive fire sent black smoke billowing from a Camden scrap yard on Friday evening, stirring concerns over air quality in ...